ClearPath Diagnostics sale to LabCorp
Other03/10/2016
Shore sold ClearPath Diagnostics to Laboratory Corporation of America Holdings. The transaction closed October 3, 2016.
Type
Other
Announced
03/10/2016
Amount
Financial data requires access
Asset class
Private Equity
Reported parties
Shore Capital Partners,ClearPath Diagnostics,Laboratory Corporation of America Holdings